Literature DB >> 21750929

The relationship between arterial stiffness and nonalcoholic fatty liver disease.

Yong-Jae Lee1, Jae-Yong Shim, Byung-Soo Moon, Youn-Ho Shin, Dong-Hyuk Jung, Jung-Hyun Lee, Hye-Ree Lee.   

Abstract

AIM: Nonalcoholic fatty liver disease (NAFLD) is currently the most common form of chronic liver disease and some studies have documented its link with cardiovascular risk factors. This study aimed to investigate the association between arterial stiffness and NAFLD.
METHODS: Among 1,442 health check-up subjects (955 men, 487 women), we examined the association between brachial-ankle pulse wave velocity (baPWV) as a measurement of arterial stiffness and the presence of NAFLD based on abdominal sonographic findings. Multivariate linear and logistic regression analyses were conducted to examine the independent association between baPWV and the presence of NAFLD in gender-specific manners.
RESULTS: In multivariate regression analysis, NAFLD was found to be independently associated with baPWV in both men and women. Moreover, in multivariate logistic regression analysis, a graded independent relation was found between higher levels of baPWV and the prevalence risk of NAFLD. Odds ratios (95% CI) for the highest vs. the lowest quartile of baPWV were 1.85 (range, 1.13-2.62) in men and 3.32 (1.45-7.62) in women after adjusting for age, smoking status, regular exercise, body mass index, blood pressure, fasting plasma glucose, triglyceride, HDL-cholesterol, hypertension and diabetes.
CONCLUSION: Arterial stiffness was independently associated with the prevalence risk for NAFLD regardless of classical CVD risk factors.

Entities:  

Mesh:

Year:  2011        PMID: 21750929     DOI: 10.1007/s10620-011-1819-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

Review 1.  Noninvasive assessment of arterial stiffness and risk of atherosclerotic events.

Authors:  James J Oliver; David J Webb
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-02-06       Impact factor: 8.311

Review 2.  Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

Authors:  Giovanni Targher; Christopher P Day; Enzo Bonora
Journal:  N Engl J Med       Date:  2010-09-30       Impact factor: 91.245

3.  Effect of cytokines on the production of endothelin by endothelial cells.

Authors:  M B Kahaleh; P S Fan
Journal:  Clin Exp Rheumatol       Date:  1997 Mar-Apr       Impact factor: 4.473

4.  Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study.

Authors:  Pierre Boutouyrie; Anne Isabelle Tropeano; Roland Asmar; Isabelle Gautier; Athanase Benetos; Patrick Lacolley; Stéphane Laurent
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

5.  Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study.

Authors:  Paolo Salvi; Raffaele Ruffini; Davide Agnoletti; Elena Magnani; Gabriele Pagliarani; Giulia Comandini; Antonino Praticò; Claudio Borghi; Athanase Benetos; Paolo Pazzi
Journal:  J Hypertens       Date:  2010-08       Impact factor: 4.844

6.  Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

Authors:  Giorgio Bedogni; Lucia Miglioli; Flora Masutti; Claudio Tiribelli; Giulio Marchesini; Stefano Bellentani
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

7.  Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.

Authors:  Nicola Villanova; Simona Moscatiello; Stefano Ramilli; Elisabetta Bugianesi; Donatella Magalotti; Ester Vanni; Marco Zoli; Giulio Marchesini
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

8.  Metabolic syndrome and arterial pulse wave velocity.

Authors:  Young-Joo Kim; Yun-Jin Kim; Byung-Mann Cho; Sangyeoup Lee
Journal:  Acta Cardiol       Date:  2010-06       Impact factor: 1.718

9.  Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease.

Authors:  Silvia Sookoian; Gustavo O Castaño; Adriana L Burgueño; María Soledad Rosselli; Tomas Fernández Gianotti; Pablo Mallardi; Julio San Martino; Carlos Jose Pirola
Journal:  Atherosclerosis       Date:  2009-10-13       Impact factor: 5.162

10.  Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.

Authors:  Seung Ha Park; Byung Ik Kim; Jung Won Yun; Jeong Wook Kim; Dong Il Park; Yong Kyun Cho; In Kyung Sung; Chang Young Park; Chong Il Sohn; Woo Kyu Jeon; Hyang Kim; Eun Jung Rhee; Won Young Lee; Sun Woo Kim
Journal:  J Gastroenterol Hepatol       Date:  2004-06       Impact factor: 4.029

View more
  23 in total

Review 1.  Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment.

Authors:  Nathalie C Leite; Cristiane A Villela-Nogueira; Claudia R L Cardoso; Gil F Salles
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 2.  Nonalcoholic fatty liver disease and cardiovascular disease.

Authors:  Hong Liu; Hong-Yun Lu
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 3.  Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis.

Authors:  Luan Rodrigues Abdallah; Ricardo Cardoso de Matos; Yves Pacheco Dias March E Souza; Débora Vieira-Soares; Gabriela Muller-Machado; Priscila Pollo-Flores
Journal:  Curr Atheroscler Rep       Date:  2020-02-04       Impact factor: 5.113

4.  Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.

Authors:  Michelle T Long; Na Wang; Martin G Larson; Gary F Mitchell; Joseph Palmisano; Ramachandran S Vasan; Udo Hoffmann; Elizabeth K Speliotes; Joseph A Vita; Emelia J Benjamin; Caroline S Fox; Naomi M Hamburg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03-05       Impact factor: 8.311

Review 5.  Nonalcoholic fatty liver disease: implications for cardiovascular risk.

Authors:  Amreen Dinani; Arun Sanyal
Journal:  Cardiovasc Endocrinol       Date:  2017-05-17

Review 6.  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.

Authors:  Vasilios G Athyros; Konstantinos Tziomalos; Niki Katsiki; Michael Doumas; Asterios Karagiannis; Dimitri P Mikhailidis
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

7.  Association between non-alcoholic fatty liver disease and arterial stiffness in the non-obese, non-hypertensive, and non-diabetic young and middle-aged Chinese population.

Authors:  Xin-yan Yu; Yi Zhao; Xiao-xiao Song; Zhen-ya Song
Journal:  J Zhejiang Univ Sci B       Date:  2014-10       Impact factor: 3.066

Review 8.  Current applications for measuring pediatric intima-media thickness.

Authors:  Ramy El Jalbout; Emile Levy; Yves Pastore; Prevost Jantchou; Chantale Lapierre; Josée Dubois
Journal:  Pediatr Radiol       Date:  2022-01-11

Review 9.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Authors:  Quentin M Anstee; Giovanni Targher; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

Review 10.  Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.

Authors:  Silvia Fargion; Marianna Porzio; Anna Ludovica Fracanzani
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.